未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 分享 收藏 分享 收藏 Lithium-Ion Batteries with Superlong Cycle-Life in Wide Temperature Range via Interfacial Alkyl-Chain Sway通过界面烷基链波动在宽温度范围内具有超长循环寿命的锂离子电池
Huang, JW; Song, LL; Zhang, B; Zhao, YX; Qian, YL; Wang, CY; Ye, XS; Zhu, FY; Zhang, WZ; Shu, YQ; Li, XT; Zhang, HB; Li, W; Ma, TZ; Zhang, XR 分享 收藏 分享 收藏 First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer: The GEMSTONE-303 Randomized Clinical TrialFirst-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer: The GEMSTONE-303 Randomized Clinical Trial
一線蘇吉帕利单抗联合化疗用于晚期胃癌：GEMSTONE-303隨機臨床試驗Zhang, Xiaotian; Wang, Jufeng; Wang, Gang; Zhang, Yanqiao; Fan, Qingxia; Lu, Chuangxin; Hu, Changlu; Sun, Meili; Wan, Yiye; Sun, Sanyuan; Wang, Junye; Zhang, Li; Shu, Yongqian; Luo, Jie; Zhu, Dan; Shen, Zhenwei; Yao, Sheng; Shi, Qingmei; Yang, Jason 分享 收藏 A phase I dose-escalation and expansion study of RMX1002, a selective E-type prostanoid receptor 4 antagonist, as monotherapy and in combination with anti-PD-1 antibody in advanced solid tumorsLiu, Dan; Gong, Jifang; Zhang, Jian; Shu, Yongqian; Wu, Hao; Liu, Tianshu; Xu, Yanhua; Zhang, Lijia; Li, Min; Hu, Xichun; Shen, Lin 分享 收藏 分享 收藏 Integrated Multi-omics Data Analysis and In Vitro Validation Reveal the Crucial Role of Glycogen Metabolism in Gastric CancerZhou, Xin; Wu, Jing; Liu, Yaoyao; Wang, Xiaping; Gao, Xuan; Xia, Xuefeng; Xu, Jing; He, Jing; Wang, Tongshan; Shu, Yongqian 分享 收藏 Induction Therapy of Tislelizumab Combined with Cisplatin and 5-Fluorouracil and Subsequent Conversion Surgery in Patients with Unresectable Advanced Esophageal Squamous Cell Carcinoma: A Phase 2, Single Center StudyTislelizumab联合顺铂和5-氟尿嘧啶的诱导治疗以及随后的转化手术治疗不可切除的晚期食管鳞状细胞癌患者: 一项2期单中心研究Xu, Tongpeng; Bai, Jianan; Zhao, Kun; Chen, Xiaofeng; Wang, Shuhui; Zhu, Shusheng; Sun, Chongqi; Zhao, Chenhui; Wang, Ting; Zhu, Ling; Hu, Meizhen; Pang, Fei; Zhang, Junling; Wang, Wei; Shu, Yongqian; Li, Fang; Zhou, Yue 分享 收藏 分享 收藏 分享 收藏 Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trialFruquintinib联合紫杉醇与安慰剂联合紫杉醇治疗胃或胃食管交界处腺癌的比较: FRUTIGA随机3期试验Wang, Feng; Shen, Lin; Guo, Weijian; Liu, Tianshu; Li, Jin; Qin, Shukui; Bai, Yuxian; Chen, Zhendong; Wang, Jufeng; Pan, Yueyin; Shu, Yongqian; Zhao, Fuyou; Cheng, Ying; Ye, Feng; Gu, Kangsheng; Zhang, Tao; Pan, Hongming; Zhong, Haijun; Zhou, Fuxiang; Qin, Yanru; Yang, Lei; Mao, Weidong; Li, Qiu; Dai, Wenxiang; Li, Wei; Wang, Shubin; Tang, Yong; Ma, Dong; Yin, Xianli; Deng, Yanhong; Yuan, Ying; Li, Man; Hu, Wenwei; Chen, Donghui; Li, Guoxin; Liu, Qiqi; Tan, Panfeng; Fan, Songhua; Shi, Michael; Su, Weiguo; Xu, Rui-Hua 分享 收藏 Effects of sintilimab plus chemotherapy as fi rst-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 studyLu, Zhihao; Kong, Li; Wang, Buhai; Wang, Junye; Liu, Lianke; Shu, Yongqian; Yang, Lei; Sun, Guogui; Cao, Guochun; Ji, Yinghua; Cui, Tongjian; Liu, Hu; Qiu, Wensheng; Li, Na; Li, Gaofeng; Luo, Hui; Hou, Xinfang; Zhang, Yanqiao; Yue, Wenbin; Xue, Liying; Liu, Zheng; Pan, Yueyin; Gao, Shegan; Wang, Xiuwen; Pan, Zhanyu; Zhang, Shuqun; Lin, Gen; Xie, Yanru; Gu, Kangsheng; Ren, Tiejun; Li, Weidong; Li, Tao; Wang, Shoufeng; He, Wei; Fan, Yun; Liang, Jun; Xia, Bing; Zhao, Li; Wang, Shuxuan; Shen, Lin 分享 收藏 Efficacy, Safety, and Immunogenicity of TQ-B211 (a Trastuzumab Biosimilar) Plus Docetaxel versus Herceptin® Plus Docetaxel for HER2-positive Metastatic Breast Cancer: a Double-blind, Randomised, Multicenter, Phase 3 TrialHu, Xichun; Zhang, Qingyuan; Wang, Shusen; Sun, Tao; Zeng, Xiaohua; Xie, Weimin; Tong, Zhongsheng; Cao, Hui; Xiong, Huihua; Wang, Xiuwen; Yang, Jin; Zhang, Shuqun; Wang, Ying; Hu, Chunhong; Lei, Kaijian; Ma, Binlin; Liu, Wei; Yu, Zhiyong; Peng, PeiJian; Yang, Hongwei; Yuan, Zhijun; Wang, Xiaojia; Wang, Xujuan; Wang, Hong; Shu, Yongqian; Li, Nanlin; Yue, Wenbin; Wang, Jingfen; Wang, Daqing; Luo, Zhiguo; Mo, Junyang; Li, Yarong; Sheng, Lili 分享 收藏 BAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural MesotheliomaBAP1缺乏会刺激肿瘤免疫微环境，是恶性胸膜间皮瘤免疫治疗反应的候选生物标志物Xu, Duo; Gao, Yanyun; Yang, Haitang; Spils, Marc; Marti, Thomas M.; Losmanova, Tereza; Su, Min; Wang, Wenxiang; Zhou, Qinghua; Dorn, Patrick; Shu, Yongqian; Peng, Ren-Wang 分享 收藏 Fat mass and obesity-associated protein (FTO) mediated m6A modification of circFAM192A promoted gastric cancer proliferation by suppressing SLC7A5 decay脂肪量和肥胖相关蛋白 (FTO) 介导的circFAM192A的m6A修饰通过抑制SLC7A5衰变促进胃癌增殖Wu, Xi; Fang, Yuan; Gu, Yunru; Shen, Haoyang; Xu, Yangyue; Xu, Tingting; Shi, Run; Xu, Duo; Zhang, Jingxin; Leng, Kai; Shu, Yongqian; Ma, Pei 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
Redox Biology.png)
OAAI